Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-16-124833

Options or other derivatives

  • Director acquired 5,193 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Coleman Mark Director 2016-05-27 Grant or award · Stock Option (Right to Buy) +5,193 5,193 D
Loading xslF345X03/a4.xml…